The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Metabolic Syndrome Is Associated with Elevated Oxidative Stress and Dysfunctional Dense High-Density Lipoprotein Particles Displaying Impaired Antioxidative Activity
Open accessAbstract
A metabolic syndrome (MetS) phenotype is characterized by insulin-resistance, atherogenic dyslipidemia, oxidative stress, and elevated cardiovascular risk and frequently involves subnormal levels of high-density lipoprotein (HDL) cholesterol. We evaluated the capacity of physicochemically distinct HDL subfractions from MetS subjects to protect low-density lipoprotein against oxidative stress. MetS subjects presented an insulin-resistant phenotype, with central obesity and elevation in systolic blood pressure and plasma triglyceride, LDL-cholesterol, apolipoprotein B, glucose, and insulin levels. Systemic oxidative stress, assessed as plasma 8-isoprostanes, was significantly higher (3.7-fold) in MetS subjects (n = 10) compared with nonobese normolipidemic controls (n = 11). In MetS, small, dense HDL3a, 3b, and 3c subfractions possessed significantly lower specific antioxidative activity (up to −23%, on a unit particle mass basis) than their counterparts in controls. In addition, HDL2a and 3a subfractions from MetS patients possessed lower total antioxidative activity (up to −41%, at equivalent plasma concentrations). The attenuated antioxidative activity of small, dense HDL subfractions correlated with systemic oxidative stress and insulin resistance and was associated with HDL particles exhibiting altered physicochemical properties (core triglyceride enrichment and cholesteryl ester depletion). We conclude that antioxidative activity of small, dense HDL subfractions of altered chemical composition is impaired in MetS and associated with elevated oxidative stress and insulin resistance. Induction of selective increase in the circulating concentrations of dense HDL subfractions may represent an innovative therapeutic approach for the attenuation of high cardiovascular risk in MetS.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Role of Insulin Resistance in Human Disease
Reaven, G. M. (1988) · Diabetes · doi:10.2337/diab.37.12.1595 · Cited by 12,154
Oxidative stress: oxidants and antioxidants
Sies, H. (1997) · Experimental Physiology · doi:10.1113/expphysiol.1997.sp004024 · Cited by 4,566
Alexander, C. M., Landsman, P. B., Teutsch, S. M., & Haffner, S. M. (2003) · Diabetes · doi:10.2337/diabetes.52.5.1210 · Cited by 1,475
Keaney, J. F., Larson, M. G., Vasan, R. S., Wilson, P. W. F., Lipinska, I., Corey, D., Massaro, J. M., Sutherland, P., Vita, J. A., & Benjamin, E. J. (2003) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000058402.34138.11 · Cited by 1,304
Oberley, L. W. (1988) · Free Radical Biology and Medicine · doi:10.1016/0891-5849(88)90036-6 · Cited by 1,105
High-density lipoprotein inhibits the oxidative modification of low-density lipoprotein
Parthasarathy, S., Barnett, J., & Fong, L. G. (1990) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(90)90314-n · Cited by 827
Paraoxonase and Atherosclerosis
Durrington, P. N., Mackness, B., & Mackness, M. I. (2001) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.21.4.473 · Cited by 818
Navab, M., Hama, S. Y., Anantharamaiah, G. M., Hassan, K., Hough, G. P., Watson, A. D., Reddy, S. T., Sevanian, A., Fonarow, G. C., & Fogelman, A. M. (2000) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)33462-3 · Cited by 668
Bonora, E., Formentini, G., Calcaterra, F., Lombardi, S., Marini, F., Zenari, L., Saggiani, F., Poli, M., Perbellini, S., Raffaelli, A., et al. (2002) · Diabetes Care · doi:10.2337/diacare.25.7.1135 · Cited by 604
Vascular inflammation and the renin-angiotensin system
Brasier, A. R., Recinos, A., & Eledrisi, M. S. (2002) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000021412.56621.a2 · Cited by 586
Chapman, M. J., Goldstein, S., Lagrange, D., & Laplaud, P. M. (1981) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)35376-1 · Cited by 553
Self-citationThe Metabolic Syndrome and Antioxidant Concentrations
Ford, E. S., Mokdad, A. H., Giles, W. H., & Brown, D. W. (2003) · Diabetes · doi:10.2337/diabetes.52.9.2346 · Cited by 458
Small, Dense HDL Particles Exert Potent Protection of Atherogenic LDL Against Oxidative Stress
Kontush, A., Chantepie, S., & Chapman, M. J. (2003) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000091338.93223.e8 · Cited by 452
Self-citationAntioxidant Activities and Oxidative Stress Byproducts in Human Hypertension
Redón, J., Oliva, M. R., Tormos, C., Giner, V., Chaves, J., Iradi, A., & Sáez, G. T. (2003) · Hypertension · doi:10.1161/01.hyp.0000068370.21009.38 · Cited by 420
HDL, its enzymes and its potential to influence lipid peroxidation
Mackness, M. I., & Durrington, P. N. (1995) · Atherosclerosis · doi:10.1016/0021-9150(94)05524-m · Cited by 418
Oxidative Stress in Arterial Hypertension: Role of NAD(P)H Oxidase
Zalba, G., José, G. S., Moreno, M. U., Fortuño, M. A., Fortuño, A., Beaumont, F. J., & Díez, J. (2001) · Hypertension · doi:10.1161/hy1201.099611 · Cited by 410
Insulin Causes Endothelial Dysfunction in Humans: Sites and Mechanisms
Arcaro, G., Cretti, A., Balzano, S., Lechi, A., Muggeo, M., Bonora, E., & Bonadonna, R. C. (2002) · Circulation · doi:10.1161/hc0502.103333 · Cited by 407
MAXWELL, S. R. J., THOMASON, H., SANDLER, D., LEGUEN, C., BAXTER, M. A., THORPE, G. H. G., JONES, A. F., & BARNETT, A. H. (1997) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.1997.1390687.x · Cited by 403
Abbott, C. A., Mackness, M. I., Kumar, S., Boulton, A. J., & Durrington, P. N. (1995) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.15.11.1812 · Cited by 387
Postprandial hypertriglyceridemia impairs endothelial function by enhanced oxidant stress
Bae, J.-H., Bassenge, E., Kim, K.-B., Kim, Y.-N., Kim, K.-S., Lee, H.-J., Moon, K.-C., Lee, M.-S., Park, K.-Y., & Schwemmer, M. (2001) · Atherosclerosis · doi:10.1016/s0021-9150(00)00601-8 · Cited by 373
Atheroprotective Effects of High-Density Lipoproteins
Assmann, G., & Nofer, J.-R. (2003) · Annual Review of Medicine · doi:10.1146/annurev.med.54.101601.152409 · Cited by 343
Glycation impairs high-density lipoprotein function
Hedrick, C. C., Thorpe, S. R., Fu, M.-X., Harper, C. M., Yoo, J., Kim, S.-M., Wong, H., & Peters, A. L. (2000) · Diabetologia · doi:10.1007/s001250050049 · Cited by 310
Apolipoprotein A-I: structure–function relationships
Frank, P. G., & Marcel, Y. L. (2000) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)32028-9 · Cited by 308
Mechanisms of Hepatic Very Low-Density Lipoprotein Overproduction in Insulin Resistance
Adeli, K., Taghibiglou, C., Van Iderstine, S. C., & Lewis, G. F. (2001) · Trends in Cardiovascular Medicine · doi:10.1016/s1050-1738(01)00084-6 · Cited by 194
Goulinet, S., & Chapman, M. J. (1997) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.17.4.786 · Cited by 191
Self-citationAntioxidant Paraoxonase 1 Activity in the Metabolic Syndrome
Sentí, M., Tomás, M., Fitó, M., Weinbrenner, T., Covas, M.-I., Sala, J., Masiá, R., & Marrugat, J. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030648 · Cited by 186
Fibrates in 2003: therapeutic action in atherogenic dyslipidaemia and future perspectives
Chapman, M. (2003) · Atherosclerosis · doi:10.1016/s0021-9150(03)00156-4 · Cited by 180
Self-citationMezzetti, A. (2000) · Cardiovascular Research · doi:10.1016/s0008-6363(00)00118-8 · Cited by 171
Hiramatsu, K., & Arimori, S. (1988) · Diabetes · doi:10.2337/diab.37.6.832 · Cited by 171
The Role of High-Density Lipoproteins in Oxidation and Inflammation
Van Lenten, B. (2001) · Trends in Cardiovascular Medicine · doi:10.1016/s1050-1738(01)00095-0 · Cited by 165
Gowri, M. S., Van der Westhuyzen, D. R., Bridges, S. R., & Anderson, J. W. (1999) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.19.9.2226 · Cited by 164
Tsimihodimos, V., Karabina, S.-A. P., Tambaki, A. P., Bairaktari, E., Goudevenos, J. A., Chapman, M. J., Elisaf, M., & Tselepis, A. D. (2002) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/hq0202.102918 · Cited by 158
Self-citationDyslipidemia in the metabolic syndrome and type 2 diabetes mellitus.
Brunzell, J. D., & Ayyobi, A. F. (2003) · The American Journal of Medicine · doi:10.1016/j.amjmed.2003.08.011 · Cited by 155
Dyslipidemia of the metabolic syndrome
Ruotolo, G., & Howard, B. V. (2002) · Current Cardiology Reports · doi:10.1007/s11886-002-0113-6 · Cited by 155
Panarotto, D., Rémillard, P., Bouffard, L., & Maheux, P. (2002) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.2002.00945.x · Cited by 137
Kunitake, S. T., Jarvis, M. R., Hamilton, R. L., & Kane, J. P. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.15.6993 · Cited by 137
Antioxidative activity of high density lipoproteins in vivo
Klimov, A. N., Gurevich, V. S., Nikiforova, A. A., Shatilina, L. V., Kuzmin, A. A., Plavinsky, S. L., & Np, T. (1993) · Atherosclerosis · doi:10.1016/0021-9150(93)90063-z · Cited by 129
Novel Function of Lecithin-Cholesterol Acyltransferase
Goyal, J., Wang, K., Liu, M., et al. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.26.16231 · Cited by 114
Curtiss, L. K., Bonnet, D. J., & Rye, K. (2000) · Biochemistry · doi:10.1021/bi992902m · Cited by 110
Abnormal Composition of High Density Lipoproteins in Non-insulin-dependent Diabetics
Biesbroeck, R., Albers, J. J., WAHL, P. W., et al. (1982) · Diabetes · doi:10.2337/diab.31.2.126 · Cited by 109
Bagdade, J. D., Buchanan, W., Kuusi, T., & Taskinen, M. (1990) · Arteriosclerosis An Official Journal of the American Heart Association Inc · doi:10.1161/01.atv.10.2.232 · Cited by 95
Chancharme, L., Thérond, P., Nigon, F., Lepage, S., Couturier, M., & Chapman, M. J. (1999) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.19.3.810 · Cited by 84
Self-citationKontush, A., de Faria, E. C., Chantepie, S., & Chapman, M. J. (2004) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000118276.87061.00 · Cited by 79
Self-citationKontush, A., Hübner, C., Finckh, B., Kohlschütter, A., & Beisiegel†, U. (1995) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(95)00115-s · Cited by 75
Self-citationYoshikawa, M., SAKUMA, N., Hibino, T., Sato, T., & Fujinami, T. (1997) · Clinical Biochemistry · doi:10.1016/s0009-9120(97)00031-3 · Cited by 72
Solà, R., Baudet, M. F., Motta, C., Maillé, M., Boisnier, C., & JACOTOT, B. (1990) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(90)90108-a · Cited by 65
Kudolo, G. B., Bressler, P., & DeFronzo, R. A. (1997) · Journal of Lipid Mediators and Cell Signalling · doi:10.1016/s0929-7855(97)00023-0 · Cited by 48
Prevention of in vitro low-density lipoprotein oxidation by an albumin-containing Lp A-I subfraction
Decossin, C., Tailleux, A., Fruchart, J., & Fiévet, C. (1995) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(94)00213-i · Cited by 23
Huang, J., Huang, Z., & Zhu, W. (1998) · Clinical Biochemistry · doi:10.1016/s0009-9120(98)00060-5 · Cited by 23
Thérond, P., Bonnefont‐Rousselot, D., Laureaux, C., Vasson, M., Motta, C., Legrand, A., & Delattre, J. (1999) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1998.0997 · Cited by 10
Cited by
Oxidative stress and metabolic disorders: Pathogenesis and therapeutic strategies
Rani, V., Deep, G., Singh, R. K., Palle, K., & Yadav, U. C. S. (2016) · Life Sciences · doi:10.1016/j.lfs.2016.02.002 · Cited by 1,139
Oxidative stress and metabolic syndrome
Roberts, C. K., & Sindhu, K. K. (2009) · Life Sciences · doi:10.1016/j.lfs.2009.02.026 · Cited by 866
Dysfunctional HDL and atherosclerotic cardiovascular disease
Rosenson, R. S., Brewer, H. B., Ansell, B. J., Barter, P., Chapman, M. J., Heinecke, J. W., Kontush, A., Tall, A. R., & Webb, N. R. (2016) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2015.124 · Cited by 822
Self-citationMetabolic Syndrome and Insulin Resistance: Underlying Causes and Modification by Exercise Training
Roberts, C. K., Hevener, A. L., & Barnard, R. J. (2013) · Comprehensive Physiology · doi:10.1002/cphy.c110062 · Cited by 831
High-Density Lipoprotein Subfractions - What the Clinicians Need to Know
Pirillo, A., Norata, G. D., & Catapano, A. L. (2013) · Cardiology · doi:10.1159/000346463 · Cited by 748
Metadata
- Authors
- Hansel, B., Giral, P., Nobecourt, E., Chantepie, S., Bruckert, E., Chapman, M. J., & Kontush, A.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2004-10-01
- Volume
- 89
- Issue
- 10
- Pages
- 4963-4971
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2161310336
- Cited by
- 477
- References
- 50
- FWCI
- 23.93
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.